NCT05058963

Brief Summary

The purpose of this study is to evaluate a virtual Mantram repetition program for adults with PTSD and substance use disorders. The program involves repetition of a personalized Mantram, which is a word or short phrase with spiritual meaning that is frequently repeated throughout the day. The program also involves slowing down thoughts and have one-pointed attention that help with stress.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 13, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 28, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
Last Updated

April 25, 2024

Status Verified

January 1, 2023

Enrollment Period

2.3 years

First QC Date

July 13, 2021

Last Update Submit

April 24, 2024

Conditions

Keywords

Post Traumatic Stress DisorderPTSDTraumaSubstance Use DisorderSUDSubstance AbuseMantramGroup therapy

Outcome Measures

Primary Outcomes (1)

  • Rate of retention in the group

    Number of sessions completed for each participant, number of participants who withdraw and/or had non-attendance after enrollment in the study

    8 weeks

Secondary Outcomes (5)

  • Alcohol consumption

    8 weeks

  • Drug consumption

    8 weeks

  • CAPS-5 PTSD Symptom Severity (past month)

    Week 4, Week 8, Week 12 follow up

  • Self-Rated PTSD Symptom Severity

    8 weeks

  • Wellbeing

    Baseline; Week 4; Week 8; Week 12 follow up. Scale Title: 12-item Short Form Health Survey , Minimum value: 0 , Maximum value : 100. The higher the score the better the outcome.

Study Arms (1)

Mantram repetition program

EXPERIMENTAL

Weekly 90 minute virtual group therapy sessions for 8 weeks run by two faciliators and will consist of 5-8 participants.

Behavioral: Mantram repetition program

Interventions

Week 1: Define and describe the characteristics of a "mantram" as taught by Eknath Easwaran and how it relates to posttraumatic stress (PTSD) Week 2: Identify ways to choose and use mantram repetition for training attention and targeting craving. Introduction to substance craving and identify triggers for use. Week 3: Describe the relationship between the PTSD/stress response, mantram repetition and the "relaxation response" Week 4: Describe at least two benefits of slowing down versus automatic pilot for stress reduction Week 5: Describe at least two benefits of one-pointed attention versus multitasking for stress reduction Week 6: Demonstrate how one-pointed attention and slowing down complement each other for making healthy choices Week 7: List at least five strategies for making mantram repetition a part of your life Week 8: Discuss applications of mantram repetition, one-pointed attention and slowing down for overall health and substance use

Mantram repetition program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • participants 18-years old or older
  • fluent in English
  • diagnosed with PTSD by a healthcare practitioner confirmed with the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5 past month version)
  • diagnosed with past-year substance use disorder other than tobacco or caffeine by a healthcare practitioner confirmed by Structured clinical interview for DSM-5 (SCID-5)
  • agreed not to participate in other therapies during the program (mindfulness, yoga, biofeedback, self-hypnosis or tai chi)
  • willing to commit to attend all sessions

You may not qualify if:

  • diagnosis of a severe or unstable medical illness that precludes safe participation in the study by a healthcare practitioner
  • diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder; or current acute psychosis or mania by a healthcare practitioner
  • participants with moderate or high risk of suicide upon screening by the Columbia Suicide Severity Rating Scale (C-SSRS)
  • have an inability to communicate in English fluently enough to complete the questionnaire.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Addiction and Mental Health

Toronto, Ontario, M5S 2S1, Canada

Location

Related Publications (1)

  • Ferkul S, Agabani Z, Minami O, Bormann J, Le Foll B, Lobo L, Hassan AN. The acceptability and feasibility of a virtual mantram program for patients with posttraumatic stress disorder and substance use disorders: mixed method results. BMC Complement Med Ther. 2024 Jan 2;24(1):9. doi: 10.1186/s12906-023-04312-1.

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticSubstance-Related DisordersWounds and Injuries

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersChemically-Induced Disorders

Study Officials

  • Ahmed Hassan, MD, MPH

    Centre for Addiction and Mental Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2021

First Posted

September 28, 2021

Study Start

May 1, 2021

Primary Completion

August 31, 2023

Study Completion

August 31, 2023

Last Updated

April 25, 2024

Record last verified: 2023-01

Locations